세계의 분자진단 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,108,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,381,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,089,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

세계 분자진단 시장 규모는 2025년에 252억 달러, 2025년-2032년의 예측 기간에 8.1%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 434억 달러에 달할 것으로 예측되고 있습니다.

분자진단은 유전체이나 프로테옴 중의 생물학적 마커를 분석하여 질병의 진단과 모니터링, 위험의 검출, 개별 환자에게 최적의 치료법의 결정 등을 실시하는 것입니다. 이 분야는 정확성, 신속성 및 치료의 개별화 가능성으로 인해 임상에서 점점 더 필수적입니다. 분자진단 시장은 PCR, NGS, 마이크로어레이, 제자리 부합법과 같은 기술을 포함하여 병원, 진단연구소, 연구기관, 재택의료의 현장에서 이용되고 있습니다. 시장 확대의 원동력이 되고 있는 것은 질병의 조기 발견에 대한 수요 증가, 감염증이나 만성 질환의 유행 증가, 분자 기술의 지속적인 혁신입니다.

시장 성장 촉진요인

세계의 분자진단 시장은 COVID-19, HIV, 간염, 결핵과 같은 감염 부담 증가와 같은 몇 가지 중요한 요인에 의해 추진되고 있습니다. 게다가, 개인화된 의료 및 표적 치료가 중시되고 정확한 분자 검사가 필요합니다. 종양학에서 동반진단의 보급과 함께 POC(Point of Care) 진단의 사용이 증가하고 있다는 것도 수요를 더욱 높이고 있습니다. 자동화, 실시간 PCR, 차세대 시퀀싱의 기술적 진보로 진단 효율성, 속도 및 감도가 향상되어 건강 관리 시스템 전반 시장 도입이 확대되고 있습니다.

시장 성장 억제요인

유망한 성장에도 불구하고 분자진단 시장은 특히 저소득 및 중산층 국가에서 장비 및 검사 비용이 높은 등의 과제에 직면하고 있습니다. 특히 신규 진단 툴에 대해서는 상환의 제한이 있어, 접근성이 제한되고 있습니다. 규제의 복잡성과 시간이 많이 걸리는 승인 프로세스도 기술 혁신과 시장 진입의 장벽이 되고 있습니다. 또한, 제한된 자원 환경에서 숙련된 검사 전문가의 부족과 인프라의 제약은 고급 분자진단의 채택을 방해합니다.

시장 기회

분자진단 시장은 종양학, 유전자검사, 약리유전체학, 감염증 관리에 있어서의 용도의 확대에 의해 큰 성장 기회를 가져오고 있습니다. 데이터 분석을 위한 인공지능과 바이오인포매틱스의 통합은 진단 전망을 바꾸고 있습니다. 연구에 대한 투자와 민간 협력 증가는 첨단 분자 검사의 혁신과 상업화를 촉진하고 있습니다. 질병의 조기 발견에 대한 의식 증가와 특히 신흥 시장의 의료 지출 증가는 시장 확대의 새로운 길을 열 것으로 예측됩니다. 게다가, 포인트 오브 케어 검사용의 휴대용으로 사용하기 쉬운 분자진단 킷의 개발에 의해 도시에서도 원격지에서도 환자 케어에 혁명이 일어나려고 하고 있습니다.

본 보고서에서는 세계의 분자진단 시장에 대해 조사했으며, 제품 유형별, 질환 영역별, 최종 용도별, 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장의 범위와 정의
• 밸류체인 분석
• 거시경제 요인
• 예측 요인- 관련성과 영향
• COVID-19의 영향 평가
• PESTLE 분석
• Porter's Five Forces 분석
• 지정학적 긴장 : 시장에 미치는 영향
• 규제와 기술의 상황

제3장 시장 역학

• 성장 촉진요인
• 억제요인
• 기회
• 동향

제4장 가격 동향 분석, 2019년-2032년

• 지역별 가격 분석
• 부문별 가격
• 가격 영향요인

제5장 세계의 분자진단 시장 전망 : 실적(2019년-2024년) 및 예측(2025년-2032년)

• 주요 하이라이트
• 세계의 분자진단 시장 전망 : 제품 유형별
  • 소개/주요 조사 결과
  • 시장 규모 추이 분석, 제품 유형별, 2019년-2024년
  • 현재 시장 규모 예측, 제품 유형별, 2025년-2032년
    • 기기
      • 중합효소 연쇄반응(PCR) 시스템
      • 제자리 부합법(In-Situ Hybridization) 및 형광 제자리 부합법(FISH) 시스템
      • DNA 시퀀싱 및 차세대 시퀀싱 플랫폼
      • 마이크로어레이
    • 시약
      • 항체
      • DNA 템플릿
      • DNA 중합효소
      • Oligonucleotide Primers
      • Deoxyribonucleotide Triphosphate(dNTP)
      • 버퍼
    • 분석 키트
    • 소모품
  • 시장 매력 분석 : 제품 유형별
• 세계의 분자진단 시장 전망 : 질환 영역별
  • 소개/주요 조사 결과
  • 시장 규모 추이 분석, 질환 영역별, 2019년-2024년
  • 현재 시장 규모 예측, 질환 영역별, 2025년-2032년
    • 감염증
    • 당뇨병
    • 심장병학
    • 종양학
    • 신장학
    • 자가면역질환
    • 피부과
    • 상처 케어
    • 기타
  • 시장 매력 분석 : 질병 영역별
• 세계의 분자진단 시장 전망 : 최종 용도별
  • 소개/주요 조사 결과
  • 시장 규모 추이 분석, 최종 용도별, 2019년-2024년
  • 현재 시장 규모 예측, 최종 용도별, 2025년-2032년
    • 병원 및 진료소
    • 진단 실험실
    • 학술연구기관
    • 바이오의약품기업
  • 시장 매력 분석 : 최종 용도별

제6장 세계의 분자진단 시장 전망 : 지역별

• 주요 하이라이트
• 시장 규모 추이 분석, 지역별, 2019년-2024년
• 현재 시장 규모 예측, 지역별, 2025년-2032년
  • 북미
  • 유럽
  • 동아시아
  • 남아시아와 오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 매력 분석 : 지역별

제7장 북미의 분자진단 시장 전망 : 실적(2019년-2024년) 및 예측(2025년-2032년)

제8장 유럽의 분자진단 시장 전망 : 실적(2019년-2024년) 및 예측(2025년-2032년)

제9장 동아시아의 분자진단 시장 전망 : 실적(2019년-2024년) 및 예측(2025년-2032년)

제10장 남아시아 및 오세아니아의 분자진단 시장 전망 : 실적(2019년-2024년) 및 예측(2025년-2032년)

제11장 라틴아메리카의 분자진단 시장 전망 : 실적(2019년-2024년) 및 예측(2025년-2032년)

제12장 중동 및 아프리카의 분자진단 시장 전망 : 실적(2019년-2024년) 및 예측(2025년-2032년)

제13장 경쟁 구도

• 시장 점유율 분석, 2025년
• 시장 구조
• 기업 프로파일
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories In
  • Merck KgaA
  • Thermo Fisher Scientific Inc
  • Agilent Technologies, Inc.
  • F. Hoffman-La Roche Ltd.
  • Illumina, Inc.
  • Qiagen NV
  • Hologic Inc.
  • Siemens Healthineers AG
  • Seegene, Inc.
  • DiaSorin SpA
  • Grifols, SA
  • bioMerieux
  • QuidelOrtho Corporation

제14장 부록

SHW

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Molecular Diagnostics Market Size (2025E): USD 25.2 Billion
• Projected Market Value (2032F): USD 43.4 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 8.1%

Molecular Diagnostics Market - Report Scope:

Molecular diagnostics involves the analysis of biological markers in the genome and proteome to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients. This segment has become increasingly essential in clinical practice due to its accuracy, speed, and potential for personalization of treatment. The molecular diagnostics market serves hospitals, diagnostic laboratories, research institutes, and homecare settings, encompassing technologies like PCR, NGS, microarrays, and in situ hybridization. Market expansion is being driven by rising demand for early disease detection, increased prevalence of infectious and chronic diseases, and continuous innovations in molecular technologies.

Market Growth Drivers:

The global molecular diagnostics market is propelled by several key factors, including the rising burden of infectious diseases such as COVID-19, HIV, hepatitis, and tuberculosis. Additionally, the growing emphasis on personalized medicine and targeted therapies necessitates accurate molecular testing. The increasing use of point-of-care diagnostics, along with the proliferation of companion diagnostics in oncology, further enhances the demand. Technological advancements in automation, real-time PCR, and next-generation sequencing are improving diagnostic efficiency, speed, and sensitivity, thereby expanding market adoption across healthcare systems.

Market Restraints:

Despite promising growth, the molecular diagnostics market faces certain challenges, such as high cost of instruments and tests, especially in low- and middle-income countries. Reimbursement limitations, particularly for novel diagnostic tools, restrict accessibility. Regulatory complexities and time-consuming approval processes also act as barriers to innovation and market entry. Furthermore, the shortage of skilled laboratory professionals and infrastructure constraints in resource-limited settings hinder the adoption of advanced molecular diagnostics.

Market Opportunities:

The molecular diagnostics market presents significant growth opportunities fueled by expanding applications in oncology, genetic testing, pharmacogenomics, and infectious disease management. The integration of artificial intelligence and bioinformatics for data analysis is transforming the diagnostic landscape. Increasing investments in research and public-private collaborations are promoting innovation and commercialization of cutting-edge molecular tests. Growing awareness about early disease detection and rising healthcare spending, especially in emerging markets, are expected to unlock new avenues for market expansion. Additionally, the development of portable and easy-to-use molecular diagnostic kits for point-of-care testing is set to revolutionize patient care in both urban and remote areas.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the molecular diagnostics market globally?
• Which technologies and applications are most widely adopted in clinical molecular diagnostics?
• How are emerging technologies like NGS and AI impacting the competitive landscape?
• Who are the leading companies in the molecular diagnostics market, and what strategies are they using to stay competitive?
• What are the key trends and future outlook for the global molecular diagnostics market?

Competitive Intelligence and Business Strategy:

These companies focus on expanding their test portfolios, developing multiplex and syndromic testing panels, and enhancing automation and throughput of diagnostic systems. Collaborations with biotechnology firms, diagnostic labs, and healthcare institutions drive access and adoption. Furthermore, companies are prioritizing regulatory approvals, market expansion in developing economies, and customer-centric strategies to reinforce their global presence.

Key Companies Profiled:

• Becton, Dickinson and Company
• Bio-Rad Laboratories In
• Merck KgaA
• Thermo Fisher Scientific Inc
• Agilent Technologies, Inc.
• F. Hoffman - La Roche Ltd.
• Illumina, Inc.
• Qiagen N.V.
• Hologic Inc.
• Siemens Healthineers AG
• Seegene, Inc.
• DiaSorin S.p.A
• Grifols, S.A.
• bioMerieux
• QuidelOrtho Corporation
• RapidBio
• Abbott Laboratories
• Danaher Corporation

Molecular Diagnostics Market Research Segmentation:

By Product Type:

• Instruments
  • * Polymerase Chain Reaction (PCR) Systems
  • * Hybridization (In-Situ Hybridization & Fish) Systems
  • * DNA Sequencing and Next-Generation Sequencing Platforms
  • * Microarrays
• Reagent
  • * Antibodies
  • * DNA Template
  • * DNA Polymerase
  • * Oligonucleotide Primers
  • * Deoxyribonucleotide Triphosphate (dNTPs)
  • * Buffer
• Assay Kits
• Consumables

By Disease Area:

• Infectious Disease
• Diabetes
• Cardiology
• Oncology
• Nephrology
• Autoimmune Disease
• Dermatology
• Wound Care
• Others

By End-use:

• Hospitals & Clinics
• Diagnostics Laboratories
• Academic and Research Institutes
• Biopharmaceutical Companies

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Molecular Diagnostics Market Snapshot 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Industry Developments and Key Market Events
• 1.5. Demand Side and Supply Side Analysis
• 1.6. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definitions
• 2.2. Value Chain Analysis
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Outlook
  • 2.3.2. Global GDP Outlook
  • 2.3.3. Global economic Growth Forecast
  • 2.3.4. Global Urbanization Growth
  • 2.3.5. Other Macro-economic Factors
• 2.4. Forecast Factors - Relevance and Impact
• 2.5. COVID-19 Impact Assessment
• 2.6. PESTLE Analysis
• 2.7. Porter's Five Forces Analysis
• 2.8. Geopolitical Tensions: Market Impact
• 2.9. Regulatory and Technology Landscape

3. Market Dynamics

• 3.1. Drivers
• 3.2. Restraints
• 3.3. Opportunities
• 3.4. Trends

4. Price Trend Analysis, 2019-2032

• 4.1. Region-wise Price Analysis
• 4.2. Price by Segments
• 4.3. Price Impact Factors

5. Global Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 5.1. Key Highlights
• 5.2. Global Molecular Diagnostics Market Outlook: Product Type
  • 5.2.1. Introduction/Key Findings
  • 5.2.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2024
  • 5.2.3. Current Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 5.2.3.1. Instruments
      • 5.2.3.1.1. Polymerase Chain Reaction (PCR) Systems
      • 5.2.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 5.2.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 5.2.3.1.4. Microarrays
    • 5.2.3.2. Reagent
      • 5.2.3.2.1. Antibodies
      • 5.2.3.2.2. DNA Template
      • 5.2.3.2.3. DNA Polymerase
      • 5.2.3.2.4. Oligonucleotide Primers
      • 5.2.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 5.2.3.2.6. Buffer
    • 5.2.3.3. Assay Kits
    • 5.2.3.4. Consumables
  • 5.2.4. Market Attractiveness Analysis: Product Type
• 5.3. Global Molecular Diagnostics Market Outlook: Disease Area
  • 5.3.1. Introduction/Key Findings
  • 5.3.2. Historical Market Size (US$ Bn) Analysis by Disease Area, 2019-2024
  • 5.3.3. Current Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 5.3.3.1. Infectious Disease
    • 5.3.3.2. Diabetes
    • 5.3.3.3. Cardiology
    • 5.3.3.4. Oncology
    • 5.3.3.5. Nephrology
    • 5.3.3.6. Autoimmune Disease
    • 5.3.3.7. Dermatology
    • 5.3.3.8. Wound Care
    • 5.3.3.9. Others
  • 5.3.4. Market Attractiveness Analysis: Disease Area
• 5.4. Global Molecular Diagnostics Market Outlook: End-use
  • 5.4.1. Introduction/Key Findings
  • 5.4.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2024
  • 5.4.3. Current Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 5.4.3.1. Hospitals & Clinics
    • 5.4.3.2. Diagnostics Laboratories
    • 5.4.3.3. Academic and Research Institutes
    • 5.4.3.4. Biopharmaceutical Companies
  • 5.4.4. Market Attractiveness Analysis: End-use

6. Global Molecular Diagnostics Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2024
• 6.3. Current Market Size (US$ Bn) Forecast, by Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia & Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. North America Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. North America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 7.4.1. Instruments
    • 7.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 7.4.1.4. Microarrays
  • 7.4.2. Reagent
    • 7.4.2.1. Antibodies
    • 7.4.2.2. DNA Template
    • 7.4.2.3. DNA Polymerase
    • 7.4.2.4. Oligonucleotide Primers
    • 7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 7.4.2.6. Buffer
  • 7.4.3. Assay Kits
  • 7.4.4. Consumables
• 7.5. North America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 7.5.1. Infectious Disease
  • 7.5.2. Diabetes
  • 7.5.3. Cardiology
  • 7.5.4. Oncology
  • 7.5.5. Nephrology
  • 7.5.6. Autoimmune Disease
  • 7.5.7. Dermatology
  • 7.5.8. Wound Care
  • 7.5.9. Others
• 7.6. North America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 7.6.1. Hospitals & Clinics
  • 7.6.2. Diagnostics Laboratories
  • 7.6.3. Academic and Research Institutes
  • 7.6.4. Biopharmaceutical Companies

8. Europe Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Europe Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. Italy
  • 8.3.3. France
  • 8.3.4. U.K.
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Rest of Europe
• 8.4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 8.4.1. Instruments
    • 8.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 8.4.1.4. Microarrays
  • 8.4.2. Reagent
    • 8.4.2.1. Antibodies
    • 8.4.2.2. DNA Template
    • 8.4.2.3. DNA Polymerase
    • 8.4.2.4. Oligonucleotide Primers
    • 8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 8.4.2.6. Buffer
  • 8.4.3. Assay Kits
  • 8.4.4. Consumables
• 8.5. Europe Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 8.5.1. Infectious Disease
  • 8.5.2. Diabetes
  • 8.5.3. Cardiology
  • 8.5.4. Oncology
  • 8.5.5. Nephrology
  • 8.5.6. Autoimmune Disease
  • 8.5.7. Dermatology
  • 8.5.8. Wound Care
  • 8.5.9. Others
• 8.6. Europe Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 8.6.1. Hospitals & Clinics
  • 8.6.2. Diagnostics Laboratories
  • 8.6.3. Academic and Research Institutes
  • 8.6.4. Biopharmaceutical Companies

9. East Asia Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. East Asia Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 9.4.1. Instruments
    • 9.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 9.4.1.4. Microarrays
  • 9.4.2. Reagent
    • 9.4.2.1. Antibodies
    • 9.4.2.2. DNA Template
    • 9.4.2.3. DNA Polymerase
    • 9.4.2.4. Oligonucleotide Primers
    • 9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 9.4.2.6. Buffer
  • 9.4.3. Assay Kits
  • 9.4.4. Consumables
• 9.5. East Asia Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 9.5.1. Infectious Disease
  • 9.5.2. Diabetes
  • 9.5.3. Cardiology
  • 9.5.4. Oncology
  • 9.5.5. Nephrology
  • 9.5.6. Autoimmune Disease
  • 9.5.7. Dermatology
  • 9.5.8. Wound Care
  • 9.5.9. Others
• 9.6. East Asia Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 9.6.1. Hospitals & Clinics
  • 9.6.2. Diagnostics Laboratories
  • 9.6.3. Academic and Research Institutes
  • 9.6.4. Biopharmaceutical Companies

10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of SAO
• 10.4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 10.4.1. Instruments
    • 10.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 10.4.1.4. Microarrays
  • 10.4.2. Reagent
    • 10.4.2.1. Antibodies
    • 10.4.2.2. DNA Template
    • 10.4.2.3. DNA Polymerase
    • 10.4.2.4. Oligonucleotide Primers
    • 10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 10.4.2.6. Buffer
  • 10.4.3. Assay Kits
  • 10.4.4. Consumables
• 10.5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 10.5.1. Infectious Disease
  • 10.5.2. Diabetes
  • 10.5.3. Cardiology
  • 10.5.4. Oncology
  • 10.5.5. Nephrology
  • 10.5.6. Autoimmune Disease
  • 10.5.7. Dermatology
  • 10.5.8. Wound Care
  • 10.5.9. Others
• 10.6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 10.6.1. Hospitals & Clinics
  • 10.6.2. Diagnostics Laboratories
  • 10.6.3. Academic and Research Institutes
  • 10.6.4. Biopharmaceutical Companies

11. Latin America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Latin America Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of LATAM
• 11.4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 11.4.1. Instruments
    • 11.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 11.4.1.4. Microarrays
  • 11.4.2. Reagent
    • 11.4.2.1. Antibodies
    • 11.4.2.2. DNA Template
    • 11.4.2.3. DNA Polymerase
    • 11.4.2.4. Oligonucleotide Primers
    • 11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 11.4.2.6. Buffer
  • 11.4.3. Assay Kits
  • 11.4.4. Consumables
• 11.5. Latin America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 11.5.1. Infectious Disease
  • 11.5.2. Diabetes
  • 11.5.3. Cardiology
  • 11.5.4. Oncology
  • 11.5.5. Nephrology
  • 11.5.6. Autoimmune Disease
  • 11.5.7. Dermatology
  • 11.5.8. Wound Care
  • 11.5.9. Others
• 11.6. Latin America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 11.6.1. Hospitals & Clinics
  • 11.6.2. Diagnostics Laboratories
  • 11.6.3. Academic and Research Institutes
  • 11.6.4. Biopharmaceutical Companies

12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 12.1. Key Highlights
• 12.2. Pricing Analysis
• 12.3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. South Africa
  • 12.3.3. Northern Africa
  • 12.3.4. Rest of MEA
• 12.4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 12.4.1. Instruments
    • 12.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 12.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 12.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 12.4.1.4. Microarrays
  • 12.4.2. Reagent
    • 12.4.2.1. Antibodies
    • 12.4.2.2. DNA Template
    • 12.4.2.3. DNA Polymerase
    • 12.4.2.4. Oligonucleotide Primers
    • 12.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 12.4.2.6. Buffer
  • 12.4.3. Assay Kits
  • 12.4.4. Consumables
• 12.5. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 12.5.1. Infectious Disease
  • 12.5.2. Diabetes
  • 12.5.3. Cardiology
  • 12.5.4. Oncology
  • 12.5.5. Nephrology
  • 12.5.6. Autoimmune Disease
  • 12.5.7. Dermatology
  • 12.5.8. Wound Care
  • 12.5.9. Others
• 12.6. Middle East & Africa Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 12.6.1. Hospitals & Clinics
  • 12.6.2. Diagnostics Laboratories
  • 12.6.3. Academic and Research Institutes
  • 12.6.4. Biopharmaceutical Companies

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles
  • 13.3.1. Becton, Dickinson and Company
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Product Portfolio/Offerings
    • 13.3.1.3. Key Financials
    • 13.3.1.4. SWOT Analysis
    • 13.3.1.5. Company Strategy and Key Developments
  • 13.3.2. Bio-Rad Laboratories In
  • 13.3.3. Merck KgaA
  • 13.3.4. Thermo Fisher Scientific Inc
  • 13.3.5. Agilent Technologies, Inc.
  • 13.3.6. F. Hoffman - La Roche Ltd.
  • 13.3.7. Illumina, Inc.
  • 13.3.8. Qiagen N.V.
  • 13.3.9. Hologic Inc.
  • 13.3.10. Siemens Healthineers AG
  • 13.3.11. Seegene, Inc.
  • 13.3.12. DiaSorin S.p.A
  • 13.3.13. Grifols, S.A.
  • 13.3.14. bioMerieux
  • 13.3.15. QuidelOrtho Corporation

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations

관련자료